| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer
|
Kawaguchi, Tomoya
|
|
2012
|
48 |
5 |
p. 672-677
6 p.
|
article
|
| 2 |
Aquaporin-4 expression in primary human central nervous system lymphomas correlates with tumour cell proliferation and phenotypic heterogeneity of the vessel wall
|
Nico, Beatrice
|
|
2012
|
48 |
5 |
p. 772-781
10 p.
|
article
|
| 3 |
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)
|
Sebban, C.
|
|
2012
|
48 |
5 |
p. 713-720
8 p.
|
article
|
| 4 |
A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
|
Nilsson, S.
|
|
2012
|
48 |
5 |
p. 678-686
9 p.
|
article
|
| 5 |
Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: A multicentre case–control study
|
Akhtar, Saeed
|
|
2012
|
48 |
5 |
p. 655-661
7 p.
|
article
|
| 6 |
Child maltreatment and breast cancer survivors: Social support makes a difference for quality of life, fatigue and cancer stress
|
Fagundes, Christopher P.
|
|
2012
|
48 |
5 |
p. 728-736
9 p.
|
article
|
| 7 |
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
|
Korse, Catharina M.
|
|
2012
|
48 |
5 |
p. 662-671
10 p.
|
article
|
| 8 |
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial
|
Gross-Goupil, M.
|
|
2012
|
48 |
5 |
p. 721-727
7 p.
|
article
|
| 9 |
Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma
|
Egberts, Friederike
|
|
2012
|
48 |
5 |
p. 695-702
8 p.
|
article
|
| 10 |
Complex expression patterns of Eph receptor tyrosine kinases and their ephrin ligands in colorectal carcinogenesis
|
Herath, Nirmitha I.
|
|
2012
|
48 |
5 |
p. 753-762
10 p.
|
article
|
| 11 |
Determinants of successful implementation of population-based cancer screening programmes
|
Lynge, Elsebeth
|
|
2012
|
48 |
5 |
p. 743-748
6 p.
|
article
|
| 12 |
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
|
|
|
2012
|
48 |
5 |
p. 599-641
43 p.
|
article
|
| 13 |
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience
|
Adamo, V.
|
|
2012
|
48 |
5 |
p. 642-647
6 p.
|
article
|
| 14 |
Merkel cell carcinoma – A population-based epidemiological study in Finland with a clinical series of 181 cases
|
Kukko, Heli
|
|
2012
|
48 |
5 |
p. 737-742
6 p.
|
article
|
| 15 |
Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup
|
McTiernan, Anne
|
|
2012
|
48 |
5 |
p. 703-712
10 p.
|
article
|
| 16 |
Primary versus secondary cytoreduction for epithelial ovarian cancer: A paired analysis of tumour pattern and surgical outcome
|
Braicu, Elena-Ioana
|
|
2012
|
48 |
5 |
p. 687-694
8 p.
|
article
|
| 17 |
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression
|
Lamers, Fieke
|
|
2012
|
48 |
5 |
p. 763-771
9 p.
|
article
|
| 18 |
The risk of oesophageal adenocarcinoma after gastrectomy for peptic ulcer disease
|
Lagergren, Jesper
|
|
2012
|
48 |
5 |
p. 749-752
4 p.
|
article
|
| 19 |
Trucut biopsy of breast lesions: The first step toward international standards in developing countries
|
Joulaee, A.
|
|
2012
|
48 |
5 |
p. 648-654
7 p.
|
article
|
Journal description